From Gut to Brain - αSynuclein pathology spreading in a new transgenic mouse model
View / Open Files
Authors
Portela Domingues, Joana Manuel
Advisors
Spillantini, Maria Grazia
Date
2021-09-30Awarding Institution
University of Cambridge
Qualification
Doctor of Philosophy (PhD)
Type
Thesis
Metadata
Show full item recordCitation
Portela Domingues, J. M. (2021). From Gut to Brain - αSynuclein pathology spreading in a new transgenic mouse model (Doctoral thesis). https://doi.org/10.17863/CAM.80410
Abstract
Age-related neurodegenerative disorders such as Parkinson’s disease (PD) represent a challenge to contemporary society. The increase in life expectancy and the lack of therapies addressing the disease cause make these disorders a high burden to patients, caretakers and society in general. Aggregation of αSynuclein (αSyn) and presence of characteristic motor symptoms are cardinal features of PD. The onset of PD motor symptoms is however preceded by non-motor symptoms that can start decades earlier. These may be associated with initiation of αSyn pathology in the peripheral nervous system, more precisely in the enteric nervous system (ENS) and/or olfactory system. Several studies have been performed in patients as well as in animal models to investigate the spreading of αSyn from the periphery to the central nervous system (CNS). Animal models of αSyn gut-to-brain spreading are usually based on the injection of αSyn aggregates or on viral overexpression of αSyn, with both cases implying external manipulation.
Hence, the main aim of this thesis was to characterise a novel, non-invasive, transgenic mouse model of spontaneous αSyn gut-to-brain spreading.This mouse model, named Vitras, expresses aggregation prone human 1-120αSyn exclusively in the gut in a αSyn-null background. To determine whether the presence of human or mouse αSyn in the background could affect the spreading of αSyn, two additional versions of the Vitras line, expressing either endogenous mouse αSyn (Vitras6J) or full-length human αSyn (VitrasBAC), were characterised. We found that gut-to-brain αSyn spreading can occur independently from the presence of endogenous full-length αSyn and was present at 3 months of age. The first gut-derived αSyn-positive neurons in the brain were detected in the dorsal motor nucleus of the vagus nerve, followed by other brainstem nuclei. In addition to the brain, gut-derived αSyn was also found in the spinal cord, lungs and heart. Although none of the mouse lines presented constipation, Vitras mice developed a hyperactive behaviour at 12 months of age.
To understand the mechanisms of αSyn spreading at a cellular level, a neuronal co-culture system of ENS-CNS neurons was set up. Moreover, in an attempt to identify compounds to target αSyn aggregation a new oligomer-modulator, Sery315b, was tested in various cellular models. Due to time limitations these studies were not completed.
In conclusion, the work demonstrated that the Vitras models are valuable tools to investigate the mechanisms of αSyn pathology spreading from the ENS to the CNS and to test possible therapies aimed at slowing down disease progression in PD.
Keywords
αSynuclein, gut-to-brain, Parkinson's disease, transgenic mouse
Sponsorship
European Commission Horizon 2020 (H2020) Marie Sk?odowska-Curie actions (721802)
Identifiers
This record's DOI: https://doi.org/10.17863/CAM.80410
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk